tell your doctor and pharmacist if you are allergic to doxycycline, minocycline, tetracycline, demeclocycline, any other medications, sulfites, or any of the ingredients in doxycycline capsules, extended-release capsules, tablets, extended-release tablets, or suspension. Ask your pharmacist for a list of the ingredients.
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: acitretin (Soriatane); anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); barbiturates such as butabarbital (Butisol), phenobarbital, and secobarbital (Seconal); bismuth subsalicylate; carbamazepine (Epitol, Tegretol, others); isotretinoin (Absorica, Amnesteem, Clavaris, Myorisan, Zenatane); penicillin; phenytoin (Dilantin, Phenytek); and proton pump inhibitors such as dexlansoprazole (Dexilant), esomeprazole (Nexium, in Vimovo), lansoprazole (Prevacid, in Prevpac), omeprazole (Prilosec, in Yosprala, Zegerid), pantoprazole (Protonix), and rabeprazole (Aciphex). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
be aware that antacids containing magnesium, aluminum, or calcium, calcium supplements, iron products, and laxatives containing magnesium interfere with doxycycline, making it less effective. Take doxycycline 2 hours before or 6 hours after taking antacids, calcium supplements, and laxatives containing magnesium. Take doxycycline 2 hours before or 4 hours after iron preparations and vitamin products that contain iron.
tell your doctor if you have or have ever had lupus (condition in which the immune system attacks many tissues and organs including the skin, joints, blood, and kidneys), intracranial hypertension (pseudotumor cerebri; high pressure in the skull that may cause headaches, blurry or double vision, vision loss, and other symptoms), a yeast infection in your mouth or vagina, surgery on your stomach, asthma, or kidney or liver disease.
you should know that doxycycline may decrease the effectiveness of hormonal contraceptives (birth control pills, patches, rings, or injections). Talk to your doctor about using another form of birth control.
tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking doxycycline, call your doctor immediately. Doxycycline can harm the fetus.
plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen. Doxycycline may make your skin sensitive to sunlight. Tell your doctor right away if you get a sunburn.
you should know that when doxycycline is used during pregnancy or in babies or children up to 8 years of age, it can cause the teeth to become permanently stained. Doxycycline should not be used in children under 8 years of age except for inhalational anthrax, Rocky Mountain spotted fever, or if your doctor decides it is needed.
Doxycycline may not tabble effectively but rather interferes with the growth and spread of certain Gram-negative bacilli. Doxycycline may also occasionally cause serious gastrointestinal effects, including nausea, vomiting, stomach pain, and anorexia. You should know that doxycycline is not recommended for children under 8 years of age unless other forms of birth control are not sufficient, your doctor will discuss suitable birth control, and doxycycline may help to reduce the risk of developing severe gastrointestinal side effects.
tell your doctor if you are breastfeeding or plan to breastfeed. If you do, you may be able to take doxycycline with or without food.
you should know that when doxycycline is used during pregnancy or in children 8 years of age and older, it can cause the teeth to become permanently stained. Doxycycline should not be used except in inhalational anthrax, Rocky Mountain spotted fever, or if your doctor decides it is needed.
Doxycycline is used for the treatment of various bacterial infections like that of chest, lung or nose (Ex. bronchitis, pneumonia, sinusitis), urinary tract (Ex. cystitis, urethritis), skin (Ex. acne), eyes or sexually transmitted diseases (Ex. gonorrhoea, syphilis, chlamydia).
It is also used to treat fevers associated with louse or tick bites and malaria (when chloroquine is ineffective). It can also be used to prevent certain infections like scrub typhus (a disease carried by small insects), Rocky Mountain spotted fever, travellers’ diarrhoea, malaria and leptospirosis.
Doxycycline:Tetracycline antibiotics
Doxycycline works by inhibiting the growth and replication of bacteria. It does this by binding to the bacterial ribosome, preventing the synthesis of proteins that are essential for the bacteria's survival.
Consult your doctor if you experience:
As part of the routine treatment of bacterial infections, antibiotics like doxycycline have gained attention as the first-line treatment for bacterial vaginosis (BV) due to their effectiveness against gram-positive pathogens. However, the effectiveness of this drug in BV is still controversial. We hypothesized that doxycycline treatment leads to a higher risk of relapse in BV patients. This study aimed to evaluate the effectiveness of doxycycline treatment in BV patients with a history of bacterial vaginosis and to investigate the risk factors for relapse.
We carried out a prospective observational study in a general outpatient clinic. Patients with a history of bacterial vaginosis were enrolled for this study. We retrospectively compared the patient’s baseline characteristics, including sex, age, and gender, between the two groups.
The risk of relapse was significantly higher in patients who had been taking doxycycline for a longer period (odds ratio (OR) 3.6, 95% confidence interval (CI) 2.0-6.2, p<0.001) and in those with a history of bacterial vaginosis (OR 1.8, 95% CI 0.9-3.6, p<0.001), compared to those who did not (OR 1.8, 95% CI 0.7-3.1, p=0.04).
The number of patients with a history of bacterial vaginosis was significantly higher in the doxycycline group (27.1% vs. 19.9%, p<0.001), with a higher mean duration of antibiotics use (median duration of antibiotic therapy, 21.8 days vs. 24.2 days, p<0.001).
Doxycycline treatment was associated with a higher risk of relapse in BV patients. However, the overall mortality rate in this study was similar to the mortality rate among other antibiotics.
We thank our funding team for their generous assistance and support. This study was funded by the University of Montreal Medical Centre (MRC), and the COH-FDA (No. 09/FDA).
This article is written for educational purposes only and does not constitute medical advice.
Bacterial vaginosis (BV) is a chronic, often life-threatening infectious disease that affects a large number of patients globally. It is most commonly caused by the bacteriumBordetella bronchiseptica, which is found in approximately 1.5 million individuals globally []. BV occurs in many parts of the world including the Middle East, Africa, and parts of Asia, with estimates indicating that up to 50% of all cases occur in Asia [].
Bacterial vaginosis, or BV, is the most common cause of bacterial vaginosis in women []. It is caused by bacteria that are resistant to other antibiotics such as doxycycline [].
BV is classified as a group of bacterial infections in which the pathogen is predominantly non-susceptible to many antibiotics, such as the tetracycline class, while doxycycline is a broad-spectrum antibiotic that specifically targets a wide range of bacteria. The drug-resistant bacteria in BV are generally responsible for the death of patients with various infections, leading to higher risk of relapse and development of antibiotic-resistant strains of bacteria.
The risk of relapse is highest in patients with a history of bacterial vaginosis, although it can occur more than once in a patient with a history of bacterial vaginosis []. This risk of relapse may be higher in the presence of prior antibiotic treatment, which increases the risk of antibiotic resistance. Therefore, treatment with antibiotics during the first few months of life should be considered before recurrence in BV patients [].
The pathogen is often found in the vagina, bladder, esophagus, mouth, and throat, which is often found in the lower urinary tract (LUT) and lower respiratory tract [].
BV can occur in the genital tract, pelvic, or thoracic system, but is more common in the upper urinary tract (UT) []. In the upper urinary tract, the most common route of transmission is through vaginal discharge and urethra [].
Antibiotics are widely used medicines to treat bacterial infections. They are often prescribed to treat bacterial infections in people with an autoimmune disease, such as Lyme disease. However, antibiotic resistance is a growing problem in the United States. Antibiotics can cause side effects in the body, and it is a good idea to check for any adverse reactions before starting treatment. If you experience any unusual symptoms, it is important to contact your doctor.
There are many different antibiotics that are effective against bacterial infections. The most common antibiotics that treat bacterial infections include amoxicillin, tetracycline, and erythromycin. Some antibiotics that are used to treat bacterial infections also include ciprofloxacin and levofloxacin. The most common antibiotics that treat bacterial infections include amoxicillin, tetracycline, and clavulanic acid. The most common antibiotics used to treat bacterial infections include clavulanic acid, penicillin, and penicillin VK. The use of penicillin VK for treating bacterial infections is discouraged.
The best antibiotics that are prescribed for treating bacterial infections include:
The most common antibiotics that are prescribed to treat bacterial infections include:
The best antibiotics that are prescribed to treat bacterial infections include:
Amoxicillin, Clavulanic acid, and Penicillin VK.
Ciprofloxacin, Amoxicillin, and Clavulanic acid.
Penicillin VK.
Doxycycline.
Bismuth subsalicylate.
Tetracycline.
Jensen, E. L. & Kirkwood, K. (2003). The construction and validation of promoter-based promoters in the human intestinal and breast-fed animal: a review. J. Food And Food Complementary Chem., 18:3-9.
L., Kirkwood, K. (2005). In-vitro induction of the expression of the gene of interest in cultured intestinal and breast-fed animal tissues by Doxycycline and Lactate-inducible promoters. Food Technol., 11:5-12.
Marks, P. A., Larkes, S. W., Eltz, S. A., Jens, P., Halden, K. A., Puschmacher, B. R., Sannella, H. T., Stauffer, J. A., Pöhler, M. L., Wernicke, R., Gershults, J. & Wiesendrass, S. (2014). Doxycycline-inducible promoters for the inducible expression of the gene of interest in cultured intestinal and breast-fed animal tissues. PLoS ONE. 17(8): e93787.
Khan, M. A., Datta, M., Ting, S. K., Roush, N., Larkes, S. W. (2009). Inducible expression of the gene of interest in cultured intestinal and breast-fed animal tissues by a transcriptional activator of the c-myc gene. 17(9): e3132.
Ranjan, A. J., Khera, M. A., Farooz, S. (2011). 17(9): e93787.
Larkes, S. W., Kirkwood, K. (2012). 17(11): e93787.
(2015).
Wiesendrass, S. (2007). 17(7): e3132.